Time-points for minimal residual disease monitoring in patients with acute myeloid leukemia who underwent allogeneic stem cells transplantation: a comparison between multiparameter flow cytometry and Wilm's tumor 1 expression

被引:0
|
作者
Rossi, G. [1 ]
Carella, A. M. [1 ]
Minervini, M. M. [1 ]
di Nardo, F. [2 ]
Greco, M. M. [1 ]
Meria, E. [1 ]
Savino, L. [1 ]
de Gills, G. P. [1 ]
Di Renzo, N. [3 ]
Melpignano, A. [4 ]
Capalbo, S. [5 ]
Pisapia, G. [6 ]
Cascavilla, N. [1 ]
机构
[1] IRCCS Casa Sollievo Sofferenza, Dept Hematol, San Giovanni Rotondo, Italy
[2] Univ Cattolica Sacro Cuore, Dept Hyg, I-00168 Rome, Italy
[3] Vito Fazzi Hosp, Dept Hematol, Lecce, Italy
[4] Perrino Hosp, Dept Hematol, Brindisi, Italy
[5] Riuniti Hosp, Dept Hematol, Foggia, Italy
[6] San Giuseppe Moscati Hosp, Dept Hematol, Taranto, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P244
引用
收藏
页码:S239 / S239
页数:1
相关论文
共 50 条
  • [1] Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: A comparison between multiparameter flow cytometry and Wilms' tumor 1 expression
    Rossi, Giovanni
    Carella, Angelo Michele
    Minervini, Maria Marta
    di Nardo, Francesco
    de Waure, Chiara
    Greco, Michele Mario
    Merla, Emanuela
    de Cillis, Giovanni Pio
    Di Renzo, Nicola
    Melpignano, Angela
    Capalbo, Silvana
    Palumbo, Gaetano
    Pisapia, Giovanni
    Cascavilla, Nicola
    LEUKEMIA RESEARCH, 2015, 39 (02) : 138 - 143
  • [2] PREDICTIVE ROLE OF MINIMAL RESIDUAL DISEASE BEFORE AND AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A COMPARISON BETWEEN MULTIPARAMETER FLOW CYTOMETRY AND WILM'S TUMOR 1 EXPRESSION
    Rossi, G.
    Carella, A. Michele
    Minervini, M. Marta
    Savino, L.
    di Nardo, F.
    de Waure, C.
    Greco, M. Mario
    Merla, E.
    Melpignano, A.
    Spirito, A.
    Capalbo, S.
    Palumbo, G.
    Perla, G.
    De Cillis, G. Pio
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S183 - S183
  • [3] Predictive role of minimal residual disease and log clearance in acute myeloid leukemia: a comparison between multiparameter flow cytometry and Wilm's tumor 1 levels
    Rossi, Giovanni
    Minervini, Maria Marta
    Melillo, Lorella
    di Nardo, Francesco
    de Waure, Chiara
    Scalzulli, Potito Rosario
    Perla, Gianni
    Valente, Daniela
    Sinisi, Nicola
    Cascavilla, Nicola
    ANNALS OF HEMATOLOGY, 2014, 93 (07) : 1149 - 1157
  • [4] Predictive role of minimal residual disease and log clearance in acute myeloid leukemia: a comparison between multiparameter flow cytometry and Wilm’s tumor 1 levels
    Giovanni Rossi
    Maria Marta Minervini
    Lorella Melillo
    Francesco di Nardo
    Chiara de Waure
    Potito Rosario Scalzulli
    Gianni Perla
    Daniela Valente
    Nicola Sinisi
    Nicola Cascavilla
    Annals of Hematology, 2014, 93 : 1149 - 1157
  • [5] Feasibility of monitoring for minimal residual disease by multiparameter flow cytometry in patients with acute myeloid leukemia
    Kern, W
    Danhauser-Riedl, S
    Schnittger, S
    Schoch, S
    Haferlach, T
    Hiddemann, W
    CYTOMETRY, 2001, 46 (05): : 328 - 328
  • [6] Combined usage of Wilms' tumor gene quantitative analysis and multiparameter flow cytometry for minimal residual disease monitoring of acute myeloid leukemia patients after allogeneic hematopoietic stem cells transplantation
    Hao, Yingchan
    Cheng, Yanhong
    Wu, Quan
    Zhang, Aimei
    Jiang, Xiaoxiao
    Xu, Xiucai
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (02) : 1403 - 1409
  • [7] MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA DETECTED BY WILMS TUMOR GENE 1 EXPRESSION AND MULTIPARAMETER FLOW CYTOMETRY
    Frairia, C.
    Aydin, S.
    Riera, L.
    Aliberti, S.
    Allione, B.
    Audisio, E.
    Stefano, D.
    Demurtas, A.
    di Celle, P. Francia
    Nicolino, B.
    Pecoraro, C.
    Stacchini, A.
    Marmont, F.
    Vitolo, U.
    HAEMATOLOGICA, 2014, 99 : 304 - 304
  • [8] Wilm's tumor 1 gene expression is a useful marker for minimal residual disease in acute myeloid leukemia
    Hsu, Jack W.
    Liu, Hong
    Jamieson, Katarzyna
    Hou, Wei
    Chang, Myron N.
    Ahrens, Kim P.
    Braylan, Raul C.
    Wingard, John R.
    BLOOD, 2007, 110 (11) : 127B - 127B
  • [9] Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission
    Konova, Zoya V.
    Parovichnikova, Elena N.
    Galtseva, Irina V.
    Kapranov, Nikolay M.
    Davydova, Julia O.
    Drokov, Mikhail Yu.
    Nareyko, Maria V.
    Popova, Natalia N.
    Dmitrova, Anna A.
    Maslikova, Ulyana V.
    Starikova, Olga S.
    Usikova, Ekaterina I.
    Mikhaltsova, Ekaterina D.
    Koroleva, Olga M.
    Vasilyeva, Vera A.
    Lobanova, Tatiana I.
    Kuzmina, Larisa A.
    Savchenko, Valeriy G.
    BLOOD, 2019, 134
  • [10] Comparison Between Multiparameter Flow Cytometry and Cytogenetic/Molecular Test for Detection of Minimal Residual Disease in Acute Myeloid Leukemia
    Wang, Xiaohua
    Lanier, Virginia
    Pataroque, Kaitlin
    Fan, Guang
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A137 - A137